The size of the Europe Interventional Neurology Market was worth USD 583.82 million in 2022 and estimated to reach USD 890.07 million by the end of 2027, with a growing potential of 8.80 %. Europe Interventional Neurology market is expected to account for the second-largest share in the market due to a favorable reimbursement scenario and advancements in technology.
Growing difficulties in treating the patients affecting by recurring stroke incidents, identification of advantages provided by interventional neurology methods, and approachability of medical reimbursement processes among the European countries are likely to fuel the market growth during the analysis period.
Also, neuro-interventional devices such as intravascular devices, stent retrievers, and flow diverters are considered significant asset popularity during the analysis time (2020-2025). The wide range of applications in identifying and treating several diseases in this interventional neurology field has increased extensively. The number of mergers and acquisitions that are happening between the market participants is growing, which is estimated to favor the market in this region.
The shortage of skilled and experienced neurosurgeons, strict regulatory bodies are likely to hamper the market growth during the period. The cost of the devices is so expensive which is one of the prime factors impeding the market growth in the interventional neurology market. Unacceptable regulatory schemes are hindering the market.
This market research report on the European Neurovascular Devices/Interventional Neurology Market has been segmented and sub-segmented into the following categories;
Europe is expected to account for the second-largest share in the global market in 2019 and the market is driven by factors such as acceptable reimbursement policies and technological developments. An increase in the patient count with nerve-related disorders and considerable endorsement of neurovascular devices amid the neurosurgeons is propelling the market growth in the region during the analysis period. Increasing old people population, growing requirement for minimally invasive neurosurgical procedures as these devices assist in lessening discomfort, and loss of blood during the treatment time.
Germany is dominating the market with the highest share in the period because of different developments in technology in the healthcare sector and government funds in enhancing the healthcare infrastructure which fuels the market growth during the review period.
The UK is the next leading country in the region with share due to continuous development of product development and commodification, increasing requirement for neurovascular devices, durable existence of device producers in the area, and availability of significant research and development investments to help these neurovascular devices product development which accelerates the market growth during the estimated period. Escalating chronic diseases like blood vessel diseases and new procedures and their development like (OCT) Optical Coherence Tomography, Fractional Flow Reserve (FFR) are some prime factors mounting the Interventional Neurology market of Europe region.
Some of the key players in Europe Interventional Neurology Market are Stryker Corporation, Abbott Laboratories, Medtronic plc, Terumo Corporation, Penumbra Inc., Johnson & Johnson, Merit Medical Systems Inc., W. L. Gore & Associates Inc., Microport Scientific Corporation, and Medikit Co., Ltd
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: email@example.com